Reporting Manager
Abu Dhabi Investment Authority
Symbol
MDLN
Shares outstanding
805,343,678 shares
Disclosed Ownership
47,515,277 shares
Ownership
5.9%
Form type
SCHEDULE 13G
Filing time
11 Feb 2026, 16:23:03 UTC
Date of event
31 Dec 2025
Next filing
07 May 2026

Key filing fact

Abu Dhabi Investment Authority disclosed 5.9% ownership in Medline Inc. Class A Common Stock, par value $0.0001 per share (MDLN) on 31 Dec 2025.

Key facts

  • Abu Dhabi Investment Authority filed SCHEDULE 13G for Medline Inc. Class A Common Stock, par value $0.0001 per share (MDLN).
  • Disclosed ownership: 5.9%.
  • Date of event: 31 Dec 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Feb 2026, 16:23.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (2)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Abu Dhabi Investment Authority 5.9% 47,515,277 517,241 46,998,036 /s/ Saif Surour Omair Maaded AlMashghouni Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
Platinum Falcon B 2018 RSC Limited 5.8% 46,998,036 0 46,998,036 /s/ Saif Surour Omair Maaded AlMashghouni Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .